Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
Users online: 332  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page

    Article Cited by others


ARNDT gottron scleromyxedema: Successful response to treatment with steroid minipulse and methotrexate

Mehta Vandana, Balachandran C, Rao Raghavendra

Year : 2009| Volume: 54| Issue : 2 | Page no: 193-195

   This article has been cited by
1 Early onset of scleromyxedema Arndt-Gottron associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins
Asma Kefi, Fatima Jaziri, Khaoula Ben Abdelghani, Sami Turki
Clinical Case Reports. 2022; 10(8)
[Pubmed]  [Google Scholar] [DOI]
2 Characterization of circulating myeloma tumor cells by next generation flowcytometry in scleromyxedema patient: a case report
Ruba Y. Taha, Saba Hasan, Firyal Ibrahim, Yannick Chantran, Hesham El Sabah, Siveen Sivaraman, Issam Al Bozom, Ahmad Al Sabbagh, Laurent Garderet, Halima El Omri
Medicine. 2020; 99(27): e20726
[Pubmed]  [Google Scholar] [DOI]
3 Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature
Hninyee Win, Krisstina Gowin
Clinical Case Reports. 2020; 8(12): 3042
[Pubmed]  [Google Scholar] [DOI]
4 Pharmacotherapy of scleromyxedema
Elisa Cinotti,Franco Rongioletti
Expert Opinion on Orphan Drugs. 2013; 1(10): 781
[Pubmed]  [Google Scholar] [DOI]


Read this article